New York Attorney General Files Insider Trading Lawsuit Against Former Emergent BioSolutions CEO Robert Kramer

New York Attorney General Letitia James filed a lawsuit against Robert Kramer for trading on undisclosed vaccine contamination news. He profited by millions.

洞察:
New York Attorney General Letitia James letitia jamesfiled a civil insider trading lawsuit on January 15, 2026, against Robert Kramer robert kramer, the former chief executive officer of Emergent BioSolutions Inc. . The lawsuit, filed in a New York state court in Manhattan, alleges that Robert Kramerviolated the Martin Act, a state securities law, by selling company stock while aware of significant contamination problems at the Baltimore vaccine manufacturing plant.
Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, U.S., May 19, 2021. Stefani Reynolds/Pool via REUTERS
Robert Kramer, President and Chief Executive Officer of Emergent BioSolutions, speaks via videoconference during a House Select Subcommittee on the Coronavirus Crisis hearing on Capitol Hill in Washington, U.S., May 19, 2021. Stefani Reynolds/Pool via REUTERS
IUX24

IUX24 提供深度財經、經濟與投資資訊,藉助 AI 發掘全球市場中最重要的信號。

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. 版權所有。

由 AI 驅動 • 精益求精

IUX24 是一個資訊與分析平台,提供新聞、市場數據、分析工具及 AI 驅動的功能,僅供資訊參考與教育用途。所提供的服務和資訊不構成投資建議、交易信號或經紀服務。投資涉及風險,用戶在作出投資決定前應審慎評估相關資訊。